NASDAQ:GNOM - Complete Genomics Stock Price, Price Target & More

$3.14 0.00 (0.00 %)
(As of 04/24/2018 08:36 AM ET)
Previous Close$3.14
Today's RangeN/A
52-Week Range$1.57 - $3.50
VolumeN/A
Average Volume133,057 shs
Market Capitalization$108.29 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Complete Genomics (NASDAQ:GNOM)

Complete Genomics logoComplete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

Receive GNOM News and Ratings via Email

Sign-up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:GNOM
CUSIPN/A
Webwww.completegenomics.com
Phone+1-650-9432800

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Complete Genomics (NASDAQ:GNOM) Frequently Asked Questions

What is Complete Genomics' stock symbol?

Complete Genomics trades on the NASDAQ under the ticker symbol "GNOM."

Has Complete Genomics been receiving favorable news coverage?

Headlines about GNOM stock have trended somewhat positive on Tuesday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Complete Genomics earned a daily sentiment score of 0.13 on Accern's scale. They also assigned headlines about the company an impact score of 49.30 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Complete Genomics?

Shares of GNOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Complete Genomics' stock price today?

One share of GNOM stock can currently be purchased for approximately $3.14.

How big of a company is Complete Genomics?

Complete Genomics has a market capitalization of $108.29 million.

How can I contact Complete Genomics?

Complete Genomics' mailing address is 2071 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The company can be reached via phone at +1-650-9432800.


MarketBeat Community Rating for Complete Genomics (GNOM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  130 (Vote Underperform)
Total Votes:  247
MarketBeat's community ratings are surveys of what our community members think about Complete Genomics and other stocks. Vote "Outperform" if you believe GNOM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNOM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Complete Genomics (NASDAQ:GNOM) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/24/2016 forward)

Earnings

Complete Genomics (NASDAQ:GNOM) Earnings History and Estimates Chart

Earnings by Quarter for Complete Genomics (NASDAQ:GNOM)

Complete Genomics (NASDAQ GNOM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2012Q312($0.52)($0.52)$8.05 million$7.27 millionViewN/AView Earnings Details
8/8/2012Q2 2012($0.58)($0.51)ViewN/AView Earnings Details
5/7/2012Q1 2012($0.61)($0.60)ViewN/AView Earnings Details
3/8/2012Q4 2011($0.64)($0.67)ViewN/AView Earnings Details
11/7/2011Q3 2011($0.55)($0.65)ViewN/AView Earnings Details
8/3/2011Q2 2011($0.47)($0.56)ViewN/AView Earnings Details
5/9/2011Q1 2011($0.52)($0.48)ViewN/AView Earnings Details
3/10/2011Q4 2010($0.65)($0.69)ViewN/AView Earnings Details
12/17/2010Q3 2010($12.64)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Complete Genomics (NASDAQ:GNOM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Complete Genomics (NASDAQ GNOM) Insider Trading and Institutional Ownership History

Insider Trading History for Complete Genomics (NASDAQ:GNOM)

Complete Genomics (NASDAQ GNOM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Complete Genomics (NASDAQ GNOM) News Headlines

Source:
DateHeadline
Comparing Complete Genomics (GNOM) & Allscripts Healthcare Solutions (MDRX)Comparing Complete Genomics (GNOM) & Allscripts Healthcare Solutions (MDRX)
www.americanbankingnews.com - February 28 at 9:16 PM
Analyzing Complete Genomics (GNOM) & Omnicell (OMCL)Analyzing Complete Genomics (GNOM) & Omnicell (OMCL)
www.americanbankingnews.com - February 23 at 4:44 PM
Complete Genomics (GNOM) vs. Simulations Plus (SLP) Financial ComparisonComplete Genomics (GNOM) vs. Simulations Plus (SLP) Financial Comparison
www.americanbankingnews.com - January 23 at 9:28 AM
Head-To-Head Analysis: Complete Genomics (GNOM) and The CompetitionHead-To-Head Analysis: Complete Genomics (GNOM) and The Competition
www.americanbankingnews.com - January 21 at 9:46 AM
Financial Contrast: Complete Genomics (GNOM) versus Its CompetitorsFinancial Contrast: Complete Genomics (GNOM) versus Its Competitors
www.americanbankingnews.com - January 20 at 9:14 PM
Critical Contrast: Complete Genomics (GNOM) & The CompetitionCritical Contrast: Complete Genomics (GNOM) & The Competition
www.americanbankingnews.com - January 18 at 11:30 PM
Complete Genomics (GNOM) vs. The Competition Head-To-Head ReviewComplete Genomics (GNOM) vs. The Competition Head-To-Head Review
www.americanbankingnews.com - January 18 at 1:32 PM
Complete Genomics (GNOM) vs. Its Peers Critical AnalysisComplete Genomics (GNOM) vs. Its Peers Critical Analysis
www.americanbankingnews.com - January 18 at 7:14 AM
Head to Head Analysis: NantHealth (NH) vs. Complete Genomics (GNOM)Head to Head Analysis: NantHealth (NH) vs. Complete Genomics (GNOM)
www.americanbankingnews.com - January 18 at 1:10 AM
Comparing NantHealth (NH) and Complete Genomics (GNOM)Comparing NantHealth (NH) and Complete Genomics (GNOM)
www.americanbankingnews.com - January 17 at 9:06 AM
Comparing Complete Genomics (GNOM) & Its PeersComparing Complete Genomics (GNOM) & Its Peers
www.americanbankingnews.com - January 17 at 5:14 AM
Complete Genomics (GNOM) and The Competition Head-To-Head ComparisonComplete Genomics (GNOM) and The Competition Head-To-Head Comparison
www.americanbankingnews.com - January 15 at 5:10 PM
Head to Head Contrast: Complete Genomics (GNOM) and Its PeersHead to Head Contrast: Complete Genomics (GNOM) and Its Peers
www.americanbankingnews.com - January 15 at 5:38 AM
Complete Genomics (GNOM) vs. Its Rivals Head to Head ReviewComplete Genomics (GNOM) vs. Its Rivals Head to Head Review
www.americanbankingnews.com - January 14 at 1:08 AM
Head-To-Head Comparison: Complete Genomics (GNOM) and Its PeersHead-To-Head Comparison: Complete Genomics (GNOM) and Its Peers
www.americanbankingnews.com - January 14 at 1:08 AM
Critical Review: Complete Genomics (GNOM) versus Its CompetitorsCritical Review: Complete Genomics (GNOM) versus Its Competitors
www.americanbankingnews.com - January 13 at 11:34 PM
Complete Genomics (GNOM) vs. The Competition Critical SurveyComplete Genomics (GNOM) vs. The Competition Critical Survey
www.americanbankingnews.com - January 12 at 1:06 PM
Complete Genomics (GNOM) versus The Competition Head to Head ReviewComplete Genomics (GNOM) versus The Competition Head to Head Review
www.americanbankingnews.com - January 10 at 5:30 PM
Comparing Complete Genomics (GNOM) & Its CompetitorsComparing Complete Genomics (GNOM) & Its Competitors
www.americanbankingnews.com - January 10 at 5:10 AM
Complete Genomics (GNOM) vs. Its Competitors Head-To-Head ComparisonComplete Genomics (GNOM) vs. Its Competitors Head-To-Head Comparison
www.americanbankingnews.com - January 7 at 11:26 PM
Head-To-Head Comparison: Complete Genomics (GNOM) vs. The CompetitionHead-To-Head Comparison: Complete Genomics (GNOM) vs. The Competition
www.americanbankingnews.com - January 6 at 9:12 PM
Head-To-Head Analysis: Complete Genomics (GNOM) & Its PeersHead-To-Head Analysis: Complete Genomics (GNOM) & Its Peers
www.americanbankingnews.com - January 6 at 7:14 PM
Analyzing Complete Genomics (GNOM) and Its PeersAnalyzing Complete Genomics (GNOM) and Its Peers
www.americanbankingnews.com - January 6 at 7:02 AM
Critical Analysis: Complete Genomics (GNOM) and Its RivalsCritical Analysis: Complete Genomics (GNOM) and Its Rivals
www.americanbankingnews.com - January 4 at 7:30 PM
Contrasting Complete Genomics (GNOM) and Its CompetitorsContrasting Complete Genomics (GNOM) and Its Competitors
www.americanbankingnews.com - January 2 at 12:18 PM
Complete Genomics (GNOM) versus The Competition Critical SurveyComplete Genomics (GNOM) versus The Competition Critical Survey
www.americanbankingnews.com - January 1 at 11:32 PM
Contrasting Complete Genomics (GNOM) and Its PeersContrasting Complete Genomics (GNOM) and Its Peers
www.americanbankingnews.com - January 1 at 3:28 AM
Head-To-Head Analysis: athenahealth (ATHN) & Complete Genomics (GNOM)Head-To-Head Analysis: athenahealth (ATHN) & Complete Genomics (GNOM)
www.americanbankingnews.com - December 30 at 11:13 AM
Complete Genomics (GNOM) & Its Competitors Critical ReviewComplete Genomics (GNOM) & Its Competitors Critical Review
www.americanbankingnews.com - December 28 at 8:18 AM
Financial Comparison: Complete Genomics (GNOM) vs. The CompetitionFinancial Comparison: Complete Genomics (GNOM) vs. The Competition
www.americanbankingnews.com - December 26 at 8:01 PM
Complete Genomics (GNOM) and Its Rivals Critical ContrastComplete Genomics (GNOM) and Its Rivals Critical Contrast
www.americanbankingnews.com - December 26 at 5:24 PM
Analyzing Complete Genomics (GNOM) & Its CompetitorsAnalyzing Complete Genomics (GNOM) & Its Competitors
www.americanbankingnews.com - December 26 at 3:28 PM
Analyzing Complete Genomics (GNOM) and Its CompetitorsAnalyzing Complete Genomics (GNOM) and Its Competitors
www.americanbankingnews.com - December 26 at 9:24 AM
Reviewing Complete Genomics (GNOM) & The CompetitionReviewing Complete Genomics (GNOM) & The Competition
www.americanbankingnews.com - December 25 at 3:28 AM
athenahealth (ATHN) vs. Complete Genomics (GNOM) Financial Surveyathenahealth (ATHN) vs. Complete Genomics (GNOM) Financial Survey
www.americanbankingnews.com - December 24 at 3:30 PM
Healthequity (HQY) vs. Complete Genomics (GNOM) Head to Head ComparisonHealthequity (HQY) vs. Complete Genomics (GNOM) Head to Head Comparison
www.americanbankingnews.com - December 24 at 8:05 AM
Reviewing Complete Genomics (GNOM) and Its CompetitorsReviewing Complete Genomics (GNOM) and Its Competitors
www.americanbankingnews.com - December 23 at 8:00 AM
Contrasting Medical Transcription Billing (MTBC) & Complete Genomics (GNOM)Contrasting Medical Transcription Billing (MTBC) & Complete Genomics (GNOM)
www.americanbankingnews.com - December 12 at 11:16 PM
Castlight Health (CSLT) vs. Complete Genomics (GNOM) Financial ContrastCastlight Health (CSLT) vs. Complete Genomics (GNOM) Financial Contrast
www.americanbankingnews.com - December 5 at 11:26 AM
Veeva Systems (VEEV) & Complete Genomics (GNOM) Head to Head AnalysisVeeva Systems (VEEV) & Complete Genomics (GNOM) Head to Head Analysis
www.americanbankingnews.com - November 22 at 9:38 PM
Reviewing Fluidigm Corporation (FLDM) and Complete Genomics (GNOM)Reviewing Fluidigm Corporation (FLDM) and Complete Genomics (GNOM)
www.americanbankingnews.com - November 6 at 3:15 PM

SEC Filings

Complete Genomics (NASDAQ:GNOM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Complete Genomics (NASDAQ:GNOM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Complete Genomics (NASDAQ GNOM) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.